Serum 25-hydroxyvitamin D, parathyroid hormone, and mortality in older men
- PMID: 20631024
- PMCID: PMC3050100
- DOI: 10.1210/jc.2010-0638
Serum 25-hydroxyvitamin D, parathyroid hormone, and mortality in older men
Abstract
Context: Low 25-hydroxyvitamin D [25(OH)D] and high PTH may contribute to increased mortality risk in older adults.
Objective: The aim of the study was to test the association between 25(OH)D, PTH, and mortality in older men.
Design and setting: The prospective Osteoporotic Fractures in Men (MrOS) study was conducted at six U.S. clinical centers.
Participants: We studied community-dwelling men at least 65 yr old (n = 1490).
Main outcome measure: Multivariate-adjusted proportional hazards models estimated the hazard ratio (HR) for mortality; cause of death was classified as cancer, cardiovascular, and other by central review of death certificates.
Results: During 7.3 yr of follow-up, 330 (22.2%) participants died: 97 from cancer, 110 from cardiovascular disease, and 106 from other causes. The adjusted HR per sd decrease in 25(OH)D for all-cause mortality was 1.01 (95% CI, 0.89, 1.14); no association between 25(OH)D and cardiovascular or other-cause mortality was seen. Unexpectedly, lower 25(OH)D levels were modestly associated with a decreased risk of cancer mortality (adjusted HR per sd decrease, 0.80; 95% CI, 0.64, 0.99). Analyzing 25(OH)D as a categorical variable did not alter these results. Higher PTH levels (log-transformed) were associated with an increased risk of all-cause mortality (adjusted HR per sd increase, 1.15; 95% CI, 1.03, 1.29) and cardiovascular mortality (adjusted HR per sd increase in PTH, 1.21; 95% CI, 1.00, 1.45).
Conclusions: In contrast to previous studies, lower 25(OH)D levels were not associated with an increased risk of all-cause or cause-specific mortality in older men. Higher PTH levels were associated with a modest increase in mortality risk.
Figures

References
-
- Bischoff-Ferrari HA, Giovannucci E, Willett WC, Dietrich T, Dawson-Hughes B 2006 Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr 84:18–28 - PubMed
-
- Holick MF 2006 High prevalence of vitamin D inadequacy and implications for health. Mayo Clin Proc 81:353–373 - PubMed
-
- Holick MF, Siris ES, Binkley N, Beard MK, Khan A, Katzer JT, Petruschke RA, Chen E, de Papp AE 2005 Prevalence of Vitamin D inadequacy among postmenopausal North American women receiving osteoporosis therapy. J Clin Endocrinol Metab 90:3215–3224 - PubMed
-
- McKenna MJ 1992 Differences in vitamin D status between countries in young adults and the elderly. Am J Med 93:69–77 - PubMed
-
- Thomas MK, Lloyd-Jones DM, Thadhani RI, Shaw AC, Deraska DJ, Kitch BT, Vamvakas EC, Dick IM, Prince RL, Finkelstein JS 1998 Hypovitaminosis D in medical inpatients. N Engl J Med 338:777–783 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- U01 AR45632/AR/NIAMS NIH HHS/United States
- K24 AR048841/AR/NIAMS NIH HHS/United States
- U01 AR45647/AR/NIAMS NIH HHS/United States
- U01 AR45614/AR/NIAMS NIH HHS/United States
- U01 AR045654/AR/NIAMS NIH HHS/United States
- U01AR45583/AR/NIAMS NIH HHS/United States
- U01-AG027810/AG/NIA NIH HHS/United States
- U01 AR045583/AR/NIAMS NIH HHS/United States
- U01 AG042140/AG/NIA NIH HHS/United States
- U01 AR045614/AR/NIAMS NIH HHS/United States
- U01 AR45654/AR/NIAMS NIH HHS/United States
- U01 AR045647/AR/NIAMS NIH HHS/United States
- U01 AR45580/AR/NIAMS NIH HHS/United States
- U01 AG027810/AG/NIA NIH HHS/United States
- UL1 RR024140/RR/NCRR NIH HHS/United States
- U01 AR045580/AR/NIAMS NIH HHS/United States
- U01 AG18197/AG/NIA NIH HHS/United States
- U01 AG018197/AG/NIA NIH HHS/United States
- U01 AR066160/AR/NIAMS NIH HHS/United States
- U01 AR045632/AR/NIAMS NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical